MARTINSRIED, Germany, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Eisbach Bio GmbH, a pioneering precision oncology company, is pleased to announce the receipt of a Texas Therapeutics Company Award from the ...
HOUSTON and MUNICH ― The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover and develop precision oncology drugs ...
The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover and develop precision oncology drugs that target synthetic ...
MARTINSRIED, Germany, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Eisbach Bio GmbH (“Eisbach” or the “Company”), a privately-held clinical-stage biotechnology company pioneering cancer medicines leveraging ...
“The premise of our whole company is that we target molecular machines, but we don’t target the engine,” Adrian Schomburg told BioWorld. Instead, “we interfere with the throttle and other highly ...
MARTINSRIED, Germany, May 6, 2024 /PRNewswire/ -- Eisbach Bio GmbH ("Eisbach" or the "Company"), a privately-held clinical-stage biotechnology company pioneering cancer medicines leveraging synthetic ...
Article ‘Count’ and ‘Share’ for Eisbach Bio GmbH based on listed parameters only. According to the parameters selected above, there are no articles from Eisbach Bio GmbH from 1 February 2025 - 31 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results